Ra Medical Systems, Inc. (RMED) Research

Ra Medical Systems, Inc. operates as a medical technology enterprise specializing in the creation, production, and sale of excimer lasers. These lasers are specifically designed for the management of vascular conditions linked to immune-mediated inflammation. Among its key offerings is the DABRA system, a minimally invasive solution that utilizes an excimer laser and a disposable catheter. This innovative technology enables physicians to perform endovascular treatments, effectively clearing arteriosclerotic blockages in the lower extremities, which are often a result of lower extremity vascular disease, through laser radiation ablation. The company primarily channels its products to the U.S. market through a network of distributors. Founded in 2002, Ra Medical Systems' corporate base is located in Carlsbad, California.

Market snapshot

Symbol
RMED
Price
$0.59
Day change
+10.00%
Market cap
$3.8M
P/E ratio
-80.47x
52-week range
0.4808-11.135
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Atreca, Inc. (BCEL)
  • Cutera, Inc. (CUTR)
  • Gritstone bio, Inc. (GRTS)
  • Vyome Holdings, Inc. (HIND)
  • Xylo Technologies Ltd. (MDGS)
  • NAYA Biosciences, Inc. (NAYA)
  • Pear Therapeutics, Inc. (PEAR)
  • ViewRay, Inc. (VRAY)

Recent insider activity

  • JENKINS DAVID A — P-Purchase (8470 shares) on 2024-01-19
  • JENKINS DAVID A — P-Purchase (8470 shares) on 2024-01-18
  • JENKINS DAVID A — P-Purchase (8470 shares) on 2024-01-16
  • JENKINS DAVID A — P-Purchase (7793 shares) on 2024-01-16
  • Francis, John P. — A-Award (25000 shares) on 2024-01-08

Open Ra Medical Systems, Inc. (RMED) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.